The possibility of preparing a live vaccine against tick-borne encephalitis from Malay langat virus TP-21
Il'enko, V.I.; Platonov, V.G.; Prozorova, I.N.; Smorodintsev, A.A.
Trudy Instituta Imeni Pastera 65: 126-132
1989
ISSN/ISBN: 0202-1447 PMID: 2560847 Accession: 041716939
Full Text Article emailed within 1 workday: $29.90
Related References
Pletnev, A.G.; Bray, M.; Hanley, K.A.; Speicher, J.; Elkins, R. 2001: Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes Journal of Virology 75(17): 8259-8267Danes, L.; Benda, R. 1960: Study of the possibility of preparing a vaccine against tick-borne encephalitis, using tissue culture methods. I. Propagation of tick-borne encephalitis virus in tissue cultures for vaccine preparation Acta Virologica 4: 25-36
Mayer, V. 1975: A live vaccine against tick-borne encephalitis: integrated studies. I. Basic properties and behaviour of the E5 "14" Clone (Langat virus) Acta Virologica 19(3): 209-218
Il'enko, V.I.; Davidenko, Z.B.; Smorodintsev, A.A. 1967: Further research on vaccine strains suitable for developing live vaccines against tick-borne encephalitis. Reactogenic and immunogenic properties of the Malayan virus Langate TP-21. used as a live vaccine against tick-borne encephalitis Tr Inst Eksp Med Akad Med Nauk Sssr 9(5): 138-146
Mayer, V.; Orolin, D.; Pogády, J.; Stárek, M.; Kubistová, K.; Gajdosová, E.; Buran, I. 1976: Experimental live tick-borne encephalitis vaccine (Labgat E5 "14" virus clone): volunteers 1 and 2 years after single-dose immunization Acta Virologica 20(3): 215-225
Platonov, V.G. 1968: Experience in the study of a live vaccine made from the tp 21 strain of malayan langat virus rhesus monkey human tick borne encephalitis Bulletin Of The World Health Organization: 425-431
Wright, P.F.; Ankrah, S.; Henderson, S.E.; Durbin, A.P.; Speicher, J.; Whitehead, S.S.; Murphy, B.R.; Pletnev, A.G. 2008: Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers Vaccine 26(7): 882-890
Smorodintsev, A.A.; Ilyenko, V.I.; Platonov, V.G. 1967: Biologic and immunogenic properties of langat tp 21 virus mouse macacus rhesus human non pathogenic in humans immunity against tick borne encephalitis live vaccine Japanese Journal of Medical Science and Biology 20(SUPP): 132-137
Tsetsarkin, K.A.; Maximova, O.A.; Liu, G.; Kenney, H.; Teterina, N.L.; Pletnev, A.G. 2019: Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus Mbio 10(2)
Pripuzova, N.S.; Tereshkina, N.V.; Gmyl, L.V.; Dzhivanyan, T.I.; Rumyantsev, A.A.; Romanova, L.I.; Mustafina, A.N.; Lashkevich, V.A.; Karganova, G.G. 2009: Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis Journal of Medical Virology 81(10): 1777-1785
Danes, L.; Benda, R. 1960: Study of the possibility of preparing a vaccine against tick-borne encephalitis, using tissue culture methods. II. the inactivation by formaldehyde of the tickborne encephalitis virus in liquids prepared from tissue cultures. Immunogenic properties Acta Virologica 4: 82-93
Benda, R.; Danes, L. 1960: Study of the possibility of preparing a vaccine against tick-borne encephalitis using tissue culture methods. 3. Experimental principles for safety tests of virus inactivation in formolized liquids Acta Virologica 4: 296-307
Benda, R.; Danes, L. 1960: Study of the possibility of preparing a vaccine against tick-borne encephalitis, using tissue culture methods. III. Experimental principles for safety tests of virus inactivation in formolized liquids Acta Virol 4(5): 296-307
Danes, L.; Benda, R. 1960: Study of the possibility of preparing a vaccine against tick-borne encephalitis, using tissue culture methods. IV. Immunisation of humans with test samples of inactivated vaccine Acta Virologica 4: 335-340
Mayer, V.; Pogády, J.; Starek, M.; Hrbka, J. 1975: A live vaccine against tick-born encephalitis: integrated studies. III. Response of man to a single dose of the E5 "14" clone (Langat virus) Acta Virologica 19(3): 229-236
Tsetsarkin, K.A.; Liu, G.; Shen, K.; Pletnev, A.G. 2016: Kissing-loop interaction between 5' and 3' ends of tick-borne Langat virus genome 'bridges the gap' between mosquito- and tick-borne flaviviruses in mechanisms of viral RNA cyclization: applications for virus attenuation and vaccine development Nucleic Acids Research 44(7): 3330-3350
Turell, M.J.; Durden, L.A. 1994: Experimental transmission of Langat (tick-borne encephalitis virus complex) virus by the soft tick Ornithodoros sonrai (Acari: Argasidae) Journal of Medical Entomology 31(1): 148-151
Bojkiewicz, E.; Toczylowski, K.; Grygorczuk, S.; Zelazowska-Rutkowska, B.; Dunaj, J.; Zebrowska, A.; Czupryna, P.; Moniuszko-Malinowska, A.; Sulik, A. 2022: The Prevalence of Asymptomatic Infections with Tick-Borne Encephalitis Virus and Attitude towards Tick-Borne Encephalitis Vaccine in the Endemic Area of Northeastern Poland Vaccines 10(8)
Kan, G.A.; Borsuk, E.A.; Vorob'eva, M.S. 1982: Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine Voprosy Virusologii 27(4): 461-464
Benda, R.; Danes, L. 1961: Study of the possibility of preparing a vaccine against tick-borne encephalitis, using tissue culture methods. V. Experimental data for the evaluation of the efficiency of formol treated vaccines in laboratory animals Acta Virologica 5(1): 37-49